This case describes the efforts of the Bill & Melinda Gates Foundation to lower the cost of production of vaccines to prevent polio infections. It is an abridged version of Case No. 620-021 with less emphasis on comparison between traditional and the new compact modular process developed with the Foundation's funding. It focuses more on the lowering of entry barriers to vaccine manufacture and some of the perceived risks associated with that.